IBDEI36I ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50757,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,50758,0)
 ;;=D47.Z9^^193^2497^178
 ;;^UTILITY(U,$J,358.3,50758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50758,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,50758,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,50758,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,50759,0)
 ;;=D05.82^^193^2497^35
 ;;^UTILITY(U,$J,358.3,50759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50759,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,50759,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,50759,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,50760,0)
 ;;=D05.81^^193^2497^37
 ;;^UTILITY(U,$J,358.3,50760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50760,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,50760,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,50760,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,50761,0)
 ;;=D05.80^^193^2497^39
 ;;^UTILITY(U,$J,358.3,50761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50761,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,50761,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,50761,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,50762,0)
 ;;=D56.8^^193^2497^191
 ;;^UTILITY(U,$J,358.3,50762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50762,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,50762,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,50762,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,50763,0)
 ;;=C82.89^^193^2497^77
 ;;^UTILITY(U,$J,358.3,50763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50763,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,50763,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,50763,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,50764,0)
 ;;=D51.8^^193^2497^198
 ;;^UTILITY(U,$J,358.3,50764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50764,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,50764,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,50764,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,50765,0)
 ;;=I80.9^^193^2497^183
 ;;^UTILITY(U,$J,358.3,50765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50765,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,50765,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,50765,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,50766,0)
 ;;=D45.^^193^2497^184
 ;;^UTILITY(U,$J,358.3,50766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50766,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,50766,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,50766,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,50767,0)
 ;;=C77.3^^193^2497^113
 ;;^UTILITY(U,$J,358.3,50767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50767,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,50767,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,50767,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,50768,0)
 ;;=C77.2^^193^2497^129
 ;;^UTILITY(U,$J,358.3,50768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50768,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,50768,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,50768,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,50769,0)
 ;;=C77.1^^193^2497^130
 ;;^UTILITY(U,$J,358.3,50769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50769,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
